Metraipolis › archive › dc_62120cbefe51

Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors — Europe PMC PMID:42058122

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42058122
DOI
10.1016/j.iotech.2026.101595
License (as archived)
solo-consultazione
Archived
2026-11-04T05:22:35.861Z
SHA-256 of the archived text
777c1ed997a209e0117b98c2edacd5787d21698f5231ac5fbb0877b26c886408
Stable URL of this page
https://metraipolis.com/documento/dc_62120cbefe51

How to cite

Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors — Europe PMC PMID:42058122 — Europe PMC (en), https://europepmc.org/article/MED/42058122 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62120cbefe51 (Metraipolis archive dc_62120cbefe51, sha256 777c1ed997a209e0117b98c2edacd5787d21698f5231ac5fbb0877b26c886408)
BibTeX
@misc{dc62120cbefe51,
  title = {Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors — Europe PMC PMID:42058122},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42058122},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62120cbefe51; sha256 777c1ed997a209e0117b98c2edacd5787d21698f5231ac5fbb0877b26c886408},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42058122. Agents can read the archived copy with the MCP tool read_document.